PSA
56
3
AIZ
82
2
EA
60
-5
SE
60
-3
WAT
48
-11
SIG
44
-3
SRE
63
2
FAST
57
-3
SBUX
37
-2
T
48
3
DAL
84
-3
WM
74
-5
SWK
50
-5
RSG
65
-3
ECL
55
-2
CPB
22
-5
CB
57
2
R
70
-3
OI
42
-3
GME
66
-5
PSA
56
3
AIZ
82
2
EA
60
-5
SE
60
-3
WAT
48
-11
SIG
44
-3
SRE
63
2
FAST
57
-3
SBUX
37
-2
T
48
3
DAL
84
-3
WM
74
-5
SWK
50
-5
RSG
65
-3
ECL
55
-2
CPB
22
-5
CB
57
2
R
70
-3
OI
42
-3
GME
66
-5
Financhill
Back

Editas Medicine Vs. Regenxbio Industry Stock Comparison

Sell
40

EDIT
Editas Medicine

Last Price:
2.53
Seasonality Move:
7.77%
Sell
21

RGNX
Regenxbio

Last Price:
10.15
Seasonality Move:
-5.66%
Sell
40
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.66. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.63. The Score for RGNX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.63
    The current trend is relatively stagnant and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 35.77 Sell
Chaikin Money Flow: -833782 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.92 - 3.38) Sell
Bollinger Bands (100): (3.13 - 4.81) Sell

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: -1215057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.06 - 10.82) Sell
Bollinger Bands (100): (9.97 - 12.83) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.04 Sell
20-day SMA: 3.11 Sell
50-day SMA: 3.34 Sell
200-day SMA: 5.33 Sell
8-day EMA: 2.95 Sell
20-day EMA: 3.08 Sell
50-day EMA: 3.37 Sell
200-day EMA: 5.1 Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.66 Sell
20-day SMA: 9.81 Sell
50-day SMA: 10.52 Sell
200-day SMA: 14.33 Sell
8-day EMA: 10.36 Sell
20-day EMA: 10.14 Sell
50-day EMA: 10.52 Sell
200-day EMA: 13.37 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):